C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 7/06 (2006.01) A61K 51/08 (2006.01) C07K 14/655 (2006.01) A61K 43/00 (1990.01) A61K 49/02 (1990.01)
Patent
CA 2102633
2102633 9221383 PCTABS00017 Radioactive-technetium-labelled and radioactive-rhenium-labelled somatostatin derivatives are disclosed for the selective detection/localisation or for the selective therapeutic treatment of tumours with somatostatin receptors. The labelled polypeptides are characterised by the general formula: R1-S1-A1-A2-(D)Trp-A3-A4-A5-Thr-S2-R2, wherein R1 is a hydrogen atom or a C1-C4 alkylcarbonyl group, R2 is an amino group, a hydroxy group or a C1-C4 alkoxy group, A1 and A5 each independently are Phe, MePhe, EtPhe, Tyr, Trp, Nal (naphthylalanyl), or Cys, A2 is Phe, MePhe, EtPhe, Tyr, Trp or Nal, A3 is Lys, MeLys or (.epsilon.-Me)Lys, A4 is Thr or Val, S1 is an amino acid sequence of 1 to 6 amino acids, selected from the group consisting of Ala, Cys, Asn, Phe, MePhe, EtPhe, Tyr, Trp, Nal, Gly, Lys, MeLys, (.epsilon.-Me)Lys, Thr, Val, Asn and Ser, and S2 is an amino acid sequence of 0 to 3 amino acids selected from the group mentioned sub S1, with the proviso that the polypeptide comprises two cysteine amino acid radicals, the metal-radionuclide being selected from a radioactive Tc or Re isotope which, as a cation, is bound covalently to the mercapto groups of the cysteine amino acid radicals.
Mallinckrodt Medical Inc.
Osler Hoskin & Harcourt Llp
LandOfFree
Radiolabelled somatostatin derivatives, their preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabelled somatostatin derivatives, their preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabelled somatostatin derivatives, their preparation... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1502007